FST and endometrial cancer: However, The Cancer Genome Atlas (TCGA) data indicate that EC patients with higher follistatin mRNA levels have a decreased 5-year survival, which implies that follistatin has important role in the progression of endometrial cancer (https://www.proteinatlas.org) [45].